278 related articles for article (PubMed ID: 15254714)
1. Adenovirus-mediated HSV-TK gene therapy using the human telomerase promoter induced apoptosis of small cell lung cancer cell line.
Song JS; Kim HP
Oncol Rep; 2004 Aug; 12(2):443-7. PubMed ID: 15254714
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated suicide gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter induced apoptosis of ovarian cancer cell line.
Song JS; Kim HP; Yoon WS; Lee KW; Kim MH; Kim KT; Kim HS; Kim YT
Biosci Biotechnol Biochem; 2003 Nov; 67(11):2344-50. PubMed ID: 14646192
[TBL] [Abstract][Full Text] [Related]
3. [A study on selective killing effect of Hsv-tk/GCV driven by human telomerase catalytic subunit promoter on human lung cancer cell A549].
Tang XJ; Wang YP; Zhou QH; Che GW; Chen XH; Zhu DX
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):148-52. PubMed ID: 17407070
[TBL] [Abstract][Full Text] [Related]
4. [An experimental study on targeting suicide gene therapy for lung cancer with HSV-TK driven by hTERT promoter].
Wang YP; Tang XJ; Zhou QH; Che GW; Chen XH; Zhu DX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):701-5. PubMed ID: 19024294
[TBL] [Abstract][Full Text] [Related]
5. [Cloning of human telomerase reverse transcriptase promoter for targeted cancer therapy].
Li F; Tan XH; Peng XJ; Cai HB; Hu DR
Di Yi Jun Yi Da Xue Xue Bao; 2005 Feb; 25(2):207-11. PubMed ID: 15699008
[TBL] [Abstract][Full Text] [Related]
6. Activity of the human telomerase catalytic subunit (hTERT) gene promoter could be increased by the SV40 enhancer.
Song JS
Biosci Biotechnol Biochem; 2004 Aug; 68(8):1634-9. PubMed ID: 15322345
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated suicide SCLC gene therapy using the increased activity of the hTERT promoter by the MMRE and SV40 enhancer.
Song JS
Biosci Biotechnol Biochem; 2005 Jan; 69(1):56-62. PubMed ID: 15665468
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of ovarian cancer cell line Skov3 with HSV-tk/GCV under the control of human telomerase reverse transcriptase gene promoter].
Song Y; Kong BH; Liu PS; Ma DX; Qu X; Jiang S
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):438-42. PubMed ID: 12974091
[TBL] [Abstract][Full Text] [Related]
9. [In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter].
Kong BH; Song Y; Ma DX; Qu X; Jiang S
Zhonghua Fu Chan Ke Za Zhi; 2004 Jun; 39(6):390-5. PubMed ID: 15312323
[TBL] [Abstract][Full Text] [Related]
10. The telomerase reverse transcriptase promoter drives efficacious tumor suicide gene therapy while preventing hepatotoxicity encountered with constitutive promoters.
Majumdar AS; Hughes DE; Lichtsteiner SP; Wang Z; Lebkowski JS; Vasserot AP
Gene Ther; 2001 Apr; 8(7):568-78. PubMed ID: 11319624
[TBL] [Abstract][Full Text] [Related]
11. FADD gene therapy using the human telomerase catalytic subunit (hTERT) gene promoter to restrict induction of apoptosis to tumors in vitro and in vivo.
Koga S; Hirohata S; Kondo Y; Komata T; Takakura M; Inoue M; Kyo S; Kondo S
Anticancer Res; 2001; 21(3B):1937-43. PubMed ID: 11497281
[TBL] [Abstract][Full Text] [Related]
12. [Construction of autocatalytic caspase-3 driven by amplified human telomerase reverse transcriptase promoter and its enhanced efficacy of inducing apoptosis in human ovarian carcinoma].
Song Y; Shen K; He CX
Zhonghua Fu Chan Ke Za Zhi; 2007 Sep; 42(9):617-22. PubMed ID: 17983518
[TBL] [Abstract][Full Text] [Related]
13. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
14. Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954.
Plumb JA; Bilsland A; Kakani R; Zhao J; Glasspool RM; Knox RJ; Evans TR; Keith WN
Oncogene; 2001 Nov; 20(53):7797-803. PubMed ID: 11753658
[TBL] [Abstract][Full Text] [Related]
15. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.
Jacob D; Davis J; Zhu H; Zhang L; Teraishi F; Wu S; Marini FC; Fang B
Clin Cancer Res; 2004 May; 10(10):3535-41. PubMed ID: 15161713
[TBL] [Abstract][Full Text] [Related]
16. Oncolytic adenovirus that overproduces ADP and replicates selectively in tumors due to hTERT promoter-regulated E4 gene expression.
Kuppuswamy M; Spencer JF; Doronin K; Tollefson AE; Wold WS; Toth K
Gene Ther; 2005 Nov; 12(22):1608-17. PubMed ID: 16034456
[TBL] [Abstract][Full Text] [Related]
17. Transcriptionally mediated inhibition of telomerase of fungal immunomodulatory protein from Ganoderma tsugae in A549 human lung adenocarcinoma cell line.
Liao CH; Hsiao YM; Hsu CP; Lin MY; Wang JC; Huang YL; Ko JL
Mol Carcinog; 2006 Apr; 45(4):220-9. PubMed ID: 16402390
[TBL] [Abstract][Full Text] [Related]
18. The insulinoma-associated 1: a novel promoter for targeted cancer gene therapy for small-cell lung cancer.
Pedersen N; Pedersen MW; Lan MS; Breslin MB; Poulsen HS
Cancer Gene Ther; 2006 Apr; 13(4):375-84. PubMed ID: 16052225
[TBL] [Abstract][Full Text] [Related]
19. hTERT promoter induces tumor-specific Bax gene expression and cell killing in syngenic mouse tumor model and prevents systemic toxicity.
Gu J; Andreeff M; Roth JA; Fang B
Gene Ther; 2002 Jan; 9(1):30-7. PubMed ID: 11850720
[TBL] [Abstract][Full Text] [Related]
20. Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatment.
Uchino J; Takayama K; Harada A; Kawakami Y; Inoue H; Curiel DT; Nakanishi Y
Cancer Gene Ther; 2005 Sep; 12(9):737-48. PubMed ID: 15861179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
